ProfileGDS4177 / 204222_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 51% 48% 81% 70% 23% 39% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated34.5751
GSM603099KU-812 non-treated30.5448
GSM603098KCL-22 Imatinib-treated242.5781
GSM603097KCL-22 non-treated104.1170
GSM603102JURL-MK1 Imatinib-treated11.9723
GSM603101JURL-MK1 non-treated21.0239